Compound Profile

Apigenin

No reliable human sleep/anxiety/cognition source was found in this pass.

Use extra caution Review before use if any apply: Pregnancy. Details

Last reviewed: Report a correctionProfile-wide ·D Preliminary
Apigenin monograph visual
Generated profile category visual
Verdict: ApigeninMaybe

Best for

  • Mild pre-sleep calm
  • Exploring chamomile’s active flavonoid
  • A gentle stack ingredient

Not ideal for

  • Significant insomnia or anxiety
  • Anyone expecting real sedation
Evidence confidence
Preliminary — mostly preclinical, little human data on isolated apigenin
Expected onset
~1 hour
Give it
1–2 weeks
Bottom line: Apigenin is the flavonoid behind chamomile’s calming reputation, but most evidence is preclinical — as an isolated supplement it is a gentle experiment, not a proven sleep aid.

On the evidence: Largely preclinical; human data on isolated apigenin is sparse.

Consider instead: Magnesiumfor a better-evidenced, low-risk sleep base

Permanent link to this scientific verdict
How strong is the evidence?Preliminary

Why not higher

  • Most evidence is animal/cell, not human
  • Little data on isolated apigenin as a supplement

Why not lower

  • A plausible mechanism and the long track record of chamomile
  • Low risk at culinary/supplemental amounts

Practical takeaway: A low-stakes option for mild pre-sleep calm. For better-evidenced help, magnesium or L-theanine are stronger starting points.

Next steps

Start here

New to this? Begin with Natural sleep aids that work.

Continue reading

Quick stats

Evidence level
Preliminary evidence
Typical onset
Varies by prep
Safety rating
Use extra caution: Interaction risk
Best for
GABAergic Signaling, NF κB, Nrf2
Avoid / review if
Pregnancy

Safety

Safety & Cautions

Review before use if any apply: Pregnancy.

High caution

Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.

  • Interaction-AwareMedication or interaction context is explicitly noted.
  • Anticoagulant CautionBleeding or anticoagulant-adjacent caution language is present.
  • Pregnancy/Breastfeeding CautionPregnancy or breastfeeding caution language is present.

Evidence Summary

Profile-wide ·D Preliminary

Evidence lens

Early signal that needs stronger human replication before practical claims.

PreliminaryPreliminary evidence

Human clinical evidence: Not the primary signal

Mechanistic / preclinical: Mechanism mappedInflammatory Signaling Modulation · Oxidative Stress Modulation · Mitochondrial Support

Research maturity: Theoretical / mechanistic researchMechanistic or unresolved evidence is kept separate from established human outcomes.

Safety boundary: Safety note availableReview before use if any apply: Pregnancy.

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Preliminary evidence

Apigenin has a preliminary evidence rating.

AdaptogenSleepFocusStress & MoodLongevity
Effects
5
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

Strong
Multiple RCTs, consistent direction, adequate effect size
Moderate
Some RCTs or consistent observational data in humans
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
Traditional / Theoretical
Traditional use only; no controlled human trials

How Apigenin Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Apigenin Works

How Apigenin WorksApigenin acts on biological target pathways via anti inflammatory, leading to gabaergic signaling.ApigeninBiological TargetBiological pathwayAnti InflammatoryGabaergic SignalingObservable outcomeAntioxidantParallel pathway
CompoundTarget / ReceptorMechanismEffect / Outcome

Dosing

No standardized dose
Common constituent in chamomile/other plants; not equivalent to chamomile clinical evidence. No validated dose from this pass.
Mechanisms & biological pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

  • Inflammatory Signaling Modulation
  • Oxidative Stress Modulation
  • Mitochondrial Support
  • Neurotransmitter Modulation
  • Stress Response Modulation
  • Neuroprotective Activity

Continue exploring

Related research paths

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Free safety checklist

Get the Apigenin evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Help improve this profile

Was this useful for your research?

These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.

Was this evidence summary clear?

Did you find what you were researching?

Compound profile context

How to interpret Apigenin

Apigenin compound profile with evidence context, key research topics, source notes, safety context, and references presented in an evidence-first format. Use this compound profile to understand mechanism, evidence quality, and practical safety context before comparing products or building a stack. A biochemical pathway connection can be useful for discovery, but it is not the same as proven benefit in humans.

When reviewing Apigenin, separate the active molecule from the product category around it. Dose form, absorption, extract standardization, medication interactions, and individual sensitivity can change the real-world risk-benefit picture.

For supplement planning, avoid combining multiple compounds with overlapping sedating, stimulating, serotonergic, blood-pressure, anticoagulant, or liver-metabolism effects unless a qualified clinician has reviewed the context.